Reported about 5 hours ago
Teva Pharmaceutical Industries has agreed to pay $450 million to resolve accusations of illegally using charities to reimburse Medicare patients' costs for its drug Copaxone and conspiring to fix prices for generic medications. The settlement includes $425 million related to a 2020 lawsuit and follows a wider investigation into pharmaceutical companies' financial support of patient assistance charities that has resulted in over $1 billion in settlements. Teva maintains it did not do anything wrong.
Source: YAHOO